Persistent Supravenous Erythematous Eruption (PSEE): A scoping review on an adverse effect related to Docetaxel infusion. Research, Society and Development, [S. l.], v. 11, n. 5, p. e21111527974, 2022. DOI: 10.33448/rsd-v11i5.27974. Disponível em: https://rsdjournal.org/rsd/article/view/27974. Acesso em: 5 dec. 2025.